Metformin Increases Proliferative Activity and Viability of Multipotent Stromal Stem Cells Isolated from Adipose Tissue Derived from Horses with Equine Metabolic Syndrome [PDF]
In this study, we investigated the influence of metformin (MF) on proliferation and viability of adipose-derived stromal cells isolated from horses (EqASCs).
Agnieszka Smieszek +8 more
doaj +3 more sources
Associations between endocrine disrupting chemicals and equine metabolic syndrome phenotypes. [PDF]
Equine Metabolic Syndrome (EMS) is characterized by abnormalities in insulin regulation, increased adiposity and laminitis, and has several similarities to human metabolic syndrome. A large amount of environmental variability in the EMS phenotype is not explained by commonly measured factors (diet, exercise, and season), suggesting that other ...
Durward-Akhurst SA +9 more
europepmc +5 more sources
Evaluation of Oxidative Stress and Mitophagy during Adipogenic Differentiation of Adipose-Derived Stem Cells Isolated from Equine Metabolic Syndrome (EMS) Horses [PDF]
Mesenchymal stem cells (MSCs) are frequently used in both human and veterinary medicine because their unique properties, such as modulating the immune response and differentiating into multiple lineages, make them a valuable tool in cell-based therapies.
Krzysztof Marycz +3 more
doaj +3 more sources
BackgroundThe prevalence of Equine Metabolic Syndrome and insulin dysregulation is increasing in the horse population. Insulin dysregulation is a risk factor for laminitis, which has significant welfare consequences for the horse.
Alexandra von Münchow +6 more
doaj +2 more sources
Equine Metabolic Syndrome (EMS) is a steadily growing life-threatening endocrine disorder linked to insulin resistance, oxidative stress, and systemic inflammation.
Daria Nawrocka +3 more
doaj +2 more sources
Faecal microbiota and serum metabolome association with equine metabolic syndrome in connemara ponies [PDF]
Background Faecal microbiome and serum metabolome have been studied in human medicine to provide a better understanding of metabolic derangements including diabetes; however, equivalent studies in equine medicine are limited.
Ahmed Saleh Al-Ansari +9 more
doaj +2 more sources
Use of principle component analysis to quantitatively score the equine metabolic syndrome phenotype in an Arabian horse population. [PDF]
Equine metabolic syndrome (EMS), like human metabolic syndrome, comprises a collection of clinical signs related to obesity, insulin dysregulation and susceptibility to secondary inflammatory disease.
Samantha L Lewis +4 more
doaj +2 more sources
Advancing in vitro vascular wall modelling using digital light processing to study hyperglycemia-driven cell changes [PDF]
BackgroundMetabolic syndrome is a pathological state, frequently associated with type 2 diabetes, which is marked by abdominal obesity, impaired insulin action, hypertension, and vascular wall changes.
Ianina Pokholenko +8 more
doaj +2 more sources
Occurrence of equine metabolic syndrome, clinical manifestations, and associated risk factors in Nigeria. [PDF]
Insulin dysregulation (ID) is central to the pathophysiology of equine metabolic syndrome (EMS), putting the horse at risk of laminitis. There is a paucity of information on the status of EMS in Nigeria.
Akinniyi OO +6 more
europepmc +2 more sources
The PTP1B Inhibitor Trodusquemine (MSI-1436) Improves Glucose Uptake in Equine Metabolic Syndrome Affected Liver through Anti-Inflammatory and Antifibrotic Activity. [PDF]
Background Hyperactivation of protein tyrosine phosphatase (PTP1B) has been associated with several metabolic malfunctions ranging from insulin resistance, metaflammation, lipotoxicity, and hyperglycaemia.
Bourebaba L +4 more
europepmc +2 more sources

